DOEF Stats & Data

Extremely limited human data exist for DOEF; dose and duration estimates are extrapolated from PIHKAL summaries and the DOx class. Onset can be delayed up to ~2 hours; do not redose for at least 3 hours to avoid accidental overdose, a known risk with DOx compounds. The long duration (often half a day or more) can be psychologically and physically taxing; plan set, setting, sleep, and nutrition accordingly. DOx compounds can produce vasoconstriction and cardiovascular strain; cold, numb extremities, severe headache, chest pain, or tingling warrant stopping further use and seeking medical attention. Avoid combining with additional stimulants (including high caffeine or nicotine) as this can worsen blood pressure, anxiety, and body load. Combining with serotonergic agents that lower seizure threshold (e.g., tramadol, DXM) or increase synaptic serotonin (e.g., MAOIs) can be dangerous; avoid these entirely. SSRIs may blunt psychedelic effects but also add serotonergic load; if present, keep DOEF doses low and avoid other serotonergic combinations. Mixing in downers (alcohol, benzodiazepines) to ‘end’ a long DOx experience increases accident and blackout risk; if used at all, extremely small amounts and only after the peak with a sober sitter, though avoidance is safer. Because potency is in the low-milligram range, weigh with a calibrated 1 mg scale and consider volumetric dosing to reduce measurement error. Mislabeling within the DOx family has occurred historically; reagent kits cannot reliably distinguish specific DOx, and only lab drug checking (FTIR/GC-MS) can confirm identity—submit a tiny sample of powder or blotter when possible. Individuals with hypertension, cardiovascular disease, or a history of panic/psychosis should avoid DOEF due to prolonged stimulation and psychological intensity.